[Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
Borris
L C
LC
Lassen
M R
MR
Christiansen
H M
HM
Møller-Larsen
F
F
Knudsen
V E
VE
Nielsen
B W
BW
D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D013927:Thrombosis / Q000517:prevention & control*
D004087:Dihydroergotamine; D006493:Heparin
Cirkulatorisk insufficiens under tromboseprofylaktisk behandling med heparin/dihydroergotamin. Virkning eller bivirkning?